Full-Time

Director of Value-Based Partnerships

BFLY Home & Community Care

Butterfly Network

Butterfly Network

201-500 employees

Handheld ultrasound device for point-of-care imaging

Compensation Overview

$200k/yr

+ Bonus + Equity

No H1B Sponsorship

New York, NY, USA + 1 more

More locations: Burlington, MA, USA

Hybrid

Category
Sales & Account Management (1)
Requirements
  • 7+ years of healthcare business development or strategic partnership experience
  • Experience working with payers, risk-bearing provider groups, population health programs, or value-based care organizations
  • Strong understanding of healthcare economics and value-based care models
  • Proven ability to build executive-level relationships and develop strategic partnerships
  • Excellent communication, negotiation, and relationship management skills
Responsibilities
  • Develop and execute a growth strategy targeting payers, value-based provider groups, PACE programs and other risk-bearing entities
  • Identify opportunities to deploy point-of-care ultrasound programs that support earlier diagnosis and proactive care management
  • Lead the full partnership lifecycle from prospecting through contracting and program launch
  • Work with partners to implement ultrasound-enabled clinical pathways that support population health goals
  • Position programs as tools to help reduce avoidable hospitalizations, emergency department visits, and downstream healthcare costs
  • Support use cases including heart failure screening and management
  • Build relationships with leaders in population health, medical management, value-based care, and clinical operations
  • Serve as a trusted partner helping organizations integrate ultrasound into care delivery workflows
  • Support commercial opportunities across partner organizations
  • Work closely with clinical, operations, and program teams to ensure successful program deployment
  • Provide market feedback to help shape product and service offerings
Desired Qualifications
  • Experience selling clinical programs, medical devices, or healthcare services
  • Familiarity with point-of-care diagnostics or imaging
  • Experience engaging PACE programs, ACOs, or integrated delivery networks
  • Knowledge of population health and care pathway redesign

Butterfly Network makes medical imaging tools, focusing on point-of-care ultrasound (POCUS). Its main product is the Butterfly iQ, a handheld ultrasound device that uses a single probe to scan the whole body. The iQ connects to a software platform, storing images, supporting telehealth, and providing advanced imaging tools. The device is sold to doctors, nurses, and medical technicians in hospitals, clinics, and rural settings, with revenue from device sales, software subscriptions, and educational resources. What sets Butterfly Network apart is its single-probe, portable design that aims to simplify ultrasound workflows and make high-quality imaging more affordable and accessible, especially in underserved areas. The company’s goal is to improve diagnostic access and patient outcomes worldwide by delivering cost-effective, easy-to-use ultrasound technology that integrates hardware and software in one connected system.

Company Size

201-500

Company Stage

IPO

Headquarters

Burlington, Massachusetts

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue grew 25% to $26.5 million, beating estimates.
  • FDA-cleared blind-sweep gestational-age AI expands maternal care and low-resource usage.
  • Gross margin reached 68.9%, helped by higher-margin licensing and software revenue.

What critics are saying

  • Philips, GE HealthCare, and Samsung Medison can bundle competing AI into fleets.
  • Butterfly Embedded remains partnership-concentrated, so one underperforming customer hits growth hard.
  • The company still guides a $21 million to $25 million adjusted EBITDA loss for 2026.

What makes Butterfly Network unique

  • Butterfly built the first handheld, single-probe whole-body ultrasound on Ultrasound-on-Chip™.
  • iQ3, cleared in January 2024, extends Butterfly's third-generation handheld POCUS platform.
  • Butterfly Embedded licenses ultrasound semiconductor technology for co-development beyond standalone devices.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Butterfly Network who can refer or advise you

Benefits

Health, dental & vision insurance

Equity

401k

PTO

Flexible hybrid work

Parental leave

Home office stipend

Rewards & recognition program

LinkedIn Learning

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
The Associated Press
Mar 10th, 2026
Butterfly Network appoints David Horsley to scale Ultrasound-on-Chip licensing initiative

Butterfly Network has appointed David Horsley as Senior Vice President of Innovation for Butterfly Embedded, its ultrasound-on-chip licensing and co-development initiative. Dr Horsley will lead strategy, partnerships and commercialisation efforts to scale the programme. Dr Horsley is a Professor of Electrical and Computer Engineering at Northeastern University and previously served as Chief Technology Officer at TDK InvenSense. He co-founded Chirp Microsystems, a sensor pioneer acquired by TDK, and is a Fellow of IEEE and the National Academy of Inventors. Butterfly Embedded enables partners to integrate the company's semiconductor-based ultrasound technology into new products and applications. Chief executive Joseph DeVivo said momentum is increasing, with growing demand and early collaborations beginning to generate revenue.

Yahoo Finance
Mar 10th, 2026
Butterfly Network shares gain 64% upside potential as Q4 revenue jumps 41% to $31.5M

Butterfly Network has received a price target increase from TD Cowen to $6 from $4.50, maintaining a Buy rating with over 64% upside potential. The upgrade follows strong fourth-quarter results showing revenue of $31.5 million, up 41% year-over-year from $22.4 million. TD Cowen highlighted Butterfly Embedded as an emerging revenue stream that could transform the company from a pure medical technology business into a broader tech player. The platform supplements Butterfly's core point-of-care ultrasound business. CEO Joseph DeVivo stated the company is shifting from a medical device focus to becoming a semiconductor-based firm centred on AI-native imaging. Butterfly Network develops ultrasound imaging solutions, including its Butterfly iQ+ and iQ3 handheld devices, serving markets worldwide.

Business Wire
Feb 26th, 2026
Butterfly Network hits record $31.5M quarterly revenue, first positive operating cash flow

Butterfly Network reported record quarterly revenue of $31.5 million for Q4 2025, up 41% year-over-year, and achieved its first quarter of positive operating cash flow. The digital health company, which makes semiconductor chip-based ultrasound devices, reached a post-money valuation based on its expanded partnerships and product initiatives. US revenue grew 55% to $26.8 million, driven partly by a co-development partnership with Midjourney that contributed $6.8 million in Q4. The agreement, disclosed in November 2025, anticipates up to $74 million in payments over five years. Gross margin improved to 67.3% from 61.4% in the prior year. For fiscal year 2026, Butterfly forecasts revenue of $117 million to $121 million, representing 20% to 24% growth, with an adjusted EBITDA loss of $21 million to $25 million.

Yahoo Finance
Feb 13th, 2026
Butterfly Network gains GovRAMP authorisation, Craig-Hallum lifts price target to $5.25

Butterfly Network has secured GovRAMP and TX-RAMP authorizations for its Butterfly iQ+/iQ3 and Compass AI ultrasound solution, enabling the company to sell cloud services to all state and local government agencies, including Texas. The certifications demonstrate compliance with the highest security standards. The digital health company reported at least 17% year-over-year revenue growth in Q4, reaching $26.2 million compared to Street estimates of $25.7 million, with full-year revenue landing at $92.3 million. Growth was primarily driven by its core business, with some contribution from its Midjourney partnership. Following these announcements, Craig-Hallum raised its price target on Butterfly Network to $5.25 from $3.25 on 21 January whilst maintaining a Buy rating on the shares.

AInvest
Nov 26th, 2025
Glenview Buys 2.8M Butterfly Shares

Larry Robbins' Glenview Capital Management acquired 2.8 million shares of Butterfly Network Inc at $2.65 per share, raising its total holdings to 12.8 million shares. This strategic move in the medical devices sector impacted Glenview's portfolio by 0.16%. Despite being overvalued compared to its GF Value, the stock saw a 22.45% price gain post-transaction.